ArticleMaterials (Basel, Switzerland)2025
Synergistic Effects of High-Modulus Additives on SBS-Modified Asphalt: Microstructural, Rheological Enhancement, and Dosage-Dependent Performance Optimization.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Performance Control and Mechanism Analysis of DCLR-Based Composite High-Modulus Asphalt Based on Synergistic Modification Effect.Materials (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study systematically investigates the synergistic modification effects of two high-modulus additives on SBS-modified asphalt through microstructural characterization and performance evaluation. Fluorescence microscopic analysis reveals that the additive particles undergo swelling over time and form an interconnected network structure via phase separation dynamics. Rheological tests demonstrate a significant enhancement in high-temperature performance: at the optimal dosage of 10 wt%, the complex modulus increases by approximately 215%, and the rutting factor improves by about 300% compared to the control group. The results from multiple stress creep recovery (MSCR) tests confirm the material's superior elastic recovery capability and reduced non-recoverable creep compliance. However, the incorporation of the additives adversely affects low-temperature ductility. The penetration of (two distinct high-modulus agents, designated as HMA-A and HMA-B) HMA-B decreases by approximately 36.8% more than that of HMA-A, accompanied by significantly lower low-temperature toughness. A dosage of 10% is identified as the critical threshold, which maximizes rutting resistance while minimizing low-temperature performance degradation. Based on these findings, this paper proposes an integrated design paradigm of "microstructure-performance-dosage," recommending HMA-B for high-stress pavement channels and HMA-A for regions with substantial temperature variations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.